Pathogenic and immunosuppressive properties of mycobacterial phenolic glycolipids

Autor: Reid Oldenburg, Caroline Demangel
Přispěvatelé: Université Paris Diderot - Paris 7 (UPD7), Immunobiologie de l'Infection - Immunobiology of Infection, Institut Pasteur [Paris] (IP)-Institut National de la Santé et de la Recherche Médicale (INSERM), This study was supported by the 'Marie Skłodowska Curie Actions' of the European Union's Seventh Framework Programme FP7/2007-2013, REA grant agreement n°317057., European Project: 317057,EC:FP7:PEOPLE,FP7-PEOPLE-2012-ITN,HOMIN(2013), Kop, Marie-Luce, Host-microbe interactions in health and disease. Interface with the immune system - HOMIN - - EC:FP7:PEOPLE2013-04-01 - 2017-03-31 - 317057 - VALID, Institut Pasteur [Paris]-Institut National de la Santé et de la Recherche Médicale (INSERM)
Jazyk: angličtina
Rok vydání: 2017
Předmět:
Zdroj: Biochimie
Biochimie, 2017, ⟨10.1016/j.biochi.2017.03.012⟩
Biochimie, Elsevier, 2017, ⟨10.1016/j.biochi.2017.03.012⟩
ISSN: 0300-9084
DOI: 10.1016/j.biochi.2017.03.012⟩
Popis: International audience; Phenolic glycolipids (PGL) are polyketide synthase products that are uniquely produced by a subset of pathogenic mycobacteria and are displayed at the bacterial cell surface, in a strategic position to interfere with host immune cells. Their expression has been associated with enhanced mycobacterial virulence in vivo, and suppression of the inflammatory responses of host phagocytes in vitro. In this review, we will present our current understanding of the mode of operation of PGL, along with functional evidence that demonstrates the evolutionary advantage conferred by PGL production for host cell invasion, intracellular persistence and evasion of host immune and bactericidal responses.
Databáze: OpenAIRE